Literature DB >> 3662906

Recognizing glaucomatous field loss with the Humphrey STATPAC.

C Enger1, A Sommer.   

Abstract

The results generated by the STATPAC program of the Humphrey Field Analyzer (Allergan Humphrey, San Leandro, Calif) from 72 eyes with documented early visual field loss and 98 normal eyes were examined. When global summary indexes and their significance levels were used to compare the tested eyes with age-matched normal values, STATPAC yielded a sensitivity of 93% and a specificity of 84%. In comparison, analysis by an independent, previously reported method yielded a sensitivity of 97% and a specificity of 90%. STATPAC results were strongly influenced by the reliability of the tested subjects.

Entities:  

Mesh:

Year:  1987        PMID: 3662906     DOI: 10.1001/archopht.1987.01060100057024

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Influence of missed catch trials on the visual field in normal subjects.

Authors:  M A Cascairo; W C Stewart; S E Sutherland
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

2.  Factors that influence the prevalence of positive catch trials in glaucoma patients.

Authors:  M Reynolds; W C Stewart; S Sutherland
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome.

Authors:  K K Gnanalingham; S Bhattacharjee; R Pennington; J Ng; N Mendoza
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

4.  Clinical evaluation of a multi-fixation campimeter for the detection of glaucomatous visual field loss.

Authors:  E Mutlukan; B E Damato; J L Jay
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

5.  Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma.

Authors:  Andrea Perdicchi; Solmaz Abdolrahimzadeh; Alessandro Cutini; Angela Ciarnella; Gian Luca Scuderi
Journal:  Clin Ophthalmol       Date:  2016-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.